---
$id: https://graph.org.ai/products/commodity/51111611
$type: Product
source: UNSPSC
code: "51111611"
title: "Teniposide"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Teniposide

**UNSPSC Code**: 51111611
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an epipodophyllotoxin compound, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 957E6438QA. European Medicines Agency schedules Teniposide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10895MIG. Teniposide generally arises in the molecular formula C32H32O13S. The term TENIPOSIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) TENIPOSIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule teniposide under HS 29389090 and SITC 54161. As of Q4 2014, TENIPOSIDE remains the US FDA Preferred Term for this commodity. Teniposide bears US NLM identifiers UMLS ID C0039512 and NCI Concept Code C857. SMILES: S1C(C2OC3C(O)C(O)C(OC4C5C(C(C6C4CC4OCOC4C6)C4CC(OC)C(O)C(OC)C4)C(=O)OC5)OC3CO2)CCC1.

